Back to search results

Restrictive Fluid Management In Liver Transplantation (REFIL)

Abroad (travel likely)Recruiting

Conditions

Liver Transplantation (LT) · End-stage Liver Disease (ESLD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Vancouver General Hospital (VGH), Vancouver, British Columbia, Canada

    Contact: Study coordinator (JeiEung Park, MD) · jeieung.park@vch.ca · 604-875-4111
    Contact: Principal Investigator (JeiEung Park, MD)

  • London Health Sciences Centre (LHSC), London, Ontario, Canada

    Contact: Study coordinator (Nelson Javier Gonzalez Valencia, MD) · nelson.gonzalezvalencia@lhsc.on.ca · 519-661-2111
    Contact: Principal Investigator (Nelson Javier Gonzalez Valencia, MD)

  • Centre hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada

    Contact: Study coordinator (Manuela Mbacfou, MSc) · manuela.mbacfou.temgoua.chum@ssss.gouv.qc.ca · 514-890-8000
    Contact: Principal Investigator (François Martin Carrier, MD)
    Michaël Chassé, MD (Sub-investigator)

  • McGill University Health Centre (MUHC), Montreal, Quebec, Canada

    Contact: Study coordinator (Stanislas Kandelman, MD) · stanislas.kandelman.med@ssss.gouv.qc.ca · 514-934-1934
    Contact: Principal Investigator (Stanislas Kandelman, MD)
Study leads

  • François Martin Carrier, MD

    Principal Investigator

    Centre hospitalier de l'Université de Montréal (CHUM)

View source on ClinicalTrials.gov(opens in a new tab)